EAM
MRTX

Exome Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Exome Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,896
Closed -$934K – 79
2023
Q4 		$934K Buy
+15,896
New +$934K 0.92% 37